Cargando…

Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial

INTRODUCTION: Efficacy of cryoballoon ablation depends on balloon‐tissue contact and ablation duration. Prolonged duration may increase extracardiac complications. The aim of this study is to determine the optimal additional ablation duration after acute pulmonary vein isolation (PVI). METHODS: Cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Keçe, Fehmi, de Riva, Marta, Naruse, Yoshihisa, Alizadeh Dehnavi, Reza, Wijnmaalen, Adrianus P., Schalij, Martin J., Zeppenfeld, Katja, Trines, Serge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850340/
https://www.ncbi.nlm.nih.gov/pubmed/30884006
http://dx.doi.org/10.1111/jce.13913
_version_ 1783469403374878720
author Keçe, Fehmi
de Riva, Marta
Naruse, Yoshihisa
Alizadeh Dehnavi, Reza
Wijnmaalen, Adrianus P.
Schalij, Martin J.
Zeppenfeld, Katja
Trines, Serge A.
author_facet Keçe, Fehmi
de Riva, Marta
Naruse, Yoshihisa
Alizadeh Dehnavi, Reza
Wijnmaalen, Adrianus P.
Schalij, Martin J.
Zeppenfeld, Katja
Trines, Serge A.
author_sort Keçe, Fehmi
collection PubMed
description INTRODUCTION: Efficacy of cryoballoon ablation depends on balloon‐tissue contact and ablation duration. Prolonged duration may increase extracardiac complications. The aim of this study is to determine the optimal additional ablation duration after acute pulmonary vein isolation (PVI). METHODS: Consecutive patients with paroxysmal AF were randomized to three groups according to additional ablation duration (90, 120, or 150 seconds) after acute PVI (time‐to‐isolation). Primary outcome was reconnection/dormant conduction (DC) after a 30 minutes waiting period. If present, additional 240 seconds ablations were performed. Ablations without time‐to‐isolation <90 seconds, esophageal temperature <18°C or decreased phrenic nerve capture were aborted. Patients were followed with 24‐hour Holter monitoring at 3, 6, and 12 months. RESULTS: Seventy‐five study patients (60 ± 11 years, 48 male) were included. Reconnection/DC per vein significantly decreased (22%, 6% and 4%) while aborted ablations remained stable (respectively 4, 5, and 7%) among the 90, 120, and 150 seconds groups. A shorter cryo‐application time, longer time‐to‐isolation, higher balloon temperature and unsuccessful ablations predicted reconnection/DC. Freedom of atrial fibrillation was, respectively, 52, 56, and 72% in 90, 120, and 150 seconds groups ( P = 0.27), while repeated procedures significantly decreased from 36% to 4% ( P = 0.041) in the longer duration group compared to shorter duration group (150 seconds vs 90 seconds group). In multivariate Cox‐regression only reconnection/DC predicted recurrence. CONCLUSION: Prolonging ablation duration after time‐to‐isolation significantly decreased reconnection/DC and repeated procedures, while recurrences and complications rates were similar. In a time‐to‐isolation approach, an additional ablation of 150 seconds ablation is the most appropriate.
format Online
Article
Text
id pubmed-6850340
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68503402019-11-18 Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial Keçe, Fehmi de Riva, Marta Naruse, Yoshihisa Alizadeh Dehnavi, Reza Wijnmaalen, Adrianus P. Schalij, Martin J. Zeppenfeld, Katja Trines, Serge A. J Cardiovasc Electrophysiol Original Articles INTRODUCTION: Efficacy of cryoballoon ablation depends on balloon‐tissue contact and ablation duration. Prolonged duration may increase extracardiac complications. The aim of this study is to determine the optimal additional ablation duration after acute pulmonary vein isolation (PVI). METHODS: Consecutive patients with paroxysmal AF were randomized to three groups according to additional ablation duration (90, 120, or 150 seconds) after acute PVI (time‐to‐isolation). Primary outcome was reconnection/dormant conduction (DC) after a 30 minutes waiting period. If present, additional 240 seconds ablations were performed. Ablations without time‐to‐isolation <90 seconds, esophageal temperature <18°C or decreased phrenic nerve capture were aborted. Patients were followed with 24‐hour Holter monitoring at 3, 6, and 12 months. RESULTS: Seventy‐five study patients (60 ± 11 years, 48 male) were included. Reconnection/DC per vein significantly decreased (22%, 6% and 4%) while aborted ablations remained stable (respectively 4, 5, and 7%) among the 90, 120, and 150 seconds groups. A shorter cryo‐application time, longer time‐to‐isolation, higher balloon temperature and unsuccessful ablations predicted reconnection/DC. Freedom of atrial fibrillation was, respectively, 52, 56, and 72% in 90, 120, and 150 seconds groups ( P = 0.27), while repeated procedures significantly decreased from 36% to 4% ( P = 0.041) in the longer duration group compared to shorter duration group (150 seconds vs 90 seconds group). In multivariate Cox‐regression only reconnection/DC predicted recurrence. CONCLUSION: Prolonging ablation duration after time‐to‐isolation significantly decreased reconnection/DC and repeated procedures, while recurrences and complications rates were similar. In a time‐to‐isolation approach, an additional ablation of 150 seconds ablation is the most appropriate. John Wiley and Sons Inc. 2019-03-29 2019-06 /pmc/articles/PMC6850340/ /pubmed/30884006 http://dx.doi.org/10.1111/jce.13913 Text en © 2019 The Authors. Journal of Cardiovascular Electrophysiology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Keçe, Fehmi
de Riva, Marta
Naruse, Yoshihisa
Alizadeh Dehnavi, Reza
Wijnmaalen, Adrianus P.
Schalij, Martin J.
Zeppenfeld, Katja
Trines, Serge A.
Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial
title Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial
title_full Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial
title_fullStr Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial
title_full_unstemmed Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial
title_short Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial
title_sort optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: a randomized controlled trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850340/
https://www.ncbi.nlm.nih.gov/pubmed/30884006
http://dx.doi.org/10.1111/jce.13913
work_keys_str_mv AT kecefehmi optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial
AT derivamarta optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial
AT naruseyoshihisa optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial
AT alizadehdehnavireza optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial
AT wijnmaalenadrianusp optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial
AT schalijmartinj optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial
AT zeppenfeldkatja optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial
AT trinessergea optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial